SW
NAVB

SVB Wealth’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

SVB Wealth’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,313
Closed -$6K – 534
2019
Q1 		$6K Hold
2,313
– – ﹤0.01% 393
2018
Q4 		$5K Hold
2,313
– – ﹤0.01% 396
2018
Q3 		$11K Hold
2,313
– – ﹤0.01% 438
2018
Q2 		$11K Hold
2,313
– – ﹤0.01% 438
2018
Q1 		$17K Hold
2,313
– – ﹤0.01% 445
2017
Q4 		$17K Hold
2,313
– – ﹤0.01% 467
2017
Q3 		$19K Hold
2,313
– – ﹤0.01% 456
2017
Q2 		$24K Hold
2,313
– – ﹤0.01% 466
2017
Q1 		$27K Hold
2,313
– – ﹤0.01% 477
2016
Q4 		$29K Hold
2,313
– – ﹤0.01% 480
2016
Q3 		$42K Hold
2,313
– – ﹤0.01% 509
2016
Q2 		$25K Hold
2,313
– – ﹤0.01% 502
2016
Q1 		$44K Hold
2,313
– – ﹤0.01% 507
2015
Q4 		$62K Hold
2,313
– – ﹤0.01% 526
2015
Q3 		$105K Hold
2,313
– – ﹤0.01% 531
2015
Q2 		$74K Hold
2,313
– – ﹤0.01% 546
2015
Q1 		$74K Hold
2,313
– – ﹤0.01% 542
2014
Q4 		$87K Buy
+2,313
New +$63.6K ﹤0.01% 530

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $305M AUM 26.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SVB Wealth's NAVB Position: Q2 2019 in Review

SVB Wealth sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2019, closing a stake of 2,313 shares — an estimated $6K sold.

SVB Wealth first reported a position in NAVB in Q4 2014 and held it in 18 quarters. The position peaked at $105K in Q3 2015. 27 funds tracked by Wall St. Rank hold NAVB as of Q2 2019.

  • SVB Wealth reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • SVB Wealth sold 2,313 Navidea Biopharmaceuticals Inc. shares in Q2 2019, an estimated $6K.
  • SVB Wealth first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2014 and held it in 18 quarters.
  • SVB Wealth's Navidea Biopharmaceuticals Inc. position peaked at $105K in Q3 2015.
  • 27 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2019.

Based on SVB Wealth's 13F filing for Q2 2019, filed 10 Jul 2019.